Genentech’s Susvimo receives new FDA indication for diabetic retinopathy www.ophthalmologytimes.com/view/genente...

The best part of the warmer Spring weather is getting back outside, especially for a bike ride! #MJHRides

FDA Approves Subcutaneous Nivolumab in All Solid Tumor Indications www.cancernetwork.com/view/fda-app...

FDA Approves Tirzepatide as First Treatment for Moderate-to-Severe Obstructive Sleep Apnea in Adults With Obesity www.pharmacytimes.com/view/fda-app...

FDA Grants Accelerated Approval to Encorafenib Plus Cetuximab and Chemo for BRAF V600E+ Metastatic Colorectal Cancer www.onclive.com/view/fda-gra...

FDA Approves Remestemcel-L in Pediatric SR-aGVHD www.cancernetwork.com/view/fda-app...

FDA Approves Ensartinib for Locally Advanced or Metastatic ALK+ NSCLC www.onclive.com/view/fda-app...

Palbociclib Combo Shows Benefit to PFS in HR+, HER2+ Breast Cancer www.targetedonc.com/view/palboci... #SABCS24

Imlunestrant With or Without Abemaciclib Boosts PFS in ESR1+, ER+/HER2– Advanced Breast Cancer www.onclive.com/view/imlunes... #SABCS24

Arlo-Cel Generates Excitement, Moves Quickly to Phase 3 Studies for Multiple Myeloma www.cgtlive.com/view/arlo-ce... #ASH24

Overflow for the overflow room resulting in some hallway session listening. I guess session 654 on myeloma was a little popular! Session started with a few great updates on isatuximab #ash24

Innovative Hemophilia Treatments Offer Hope Amid Lingering Clinical Challenges www.hcplive.com/view/innovat... #ash24

Daratumumab Significantly Improves PFS, Extends OS in Smoldering Myeloma www.onclive.com/view/daratum... #ash24

Sitting in an excellent presentation by @lymphomadoc.bsky.social at another packed session on aggressive lymphomas at #ash24

Tandem CD20/CD19 CAR Zamto-Cel Shows Promise in DLBCL www.cgtlive.com/view/tandem-... #ASH24

Session time! Packed house for cell therapies for aggressive lymphomas at #ash24

Kicking off the annual MPN Heroes recognition program at #ASH24 - one of my favorite events of the year

Listen to my MSK colleague Eytan Stein "Revumenib Could Provide New Path to Transplant in R/R KMT2A+ Acute Leukemia" @mskcancercenter.bsky.social #leusm #ASH24 @onclive.bsky.social www.onclive.com/view/revumen...

Nice full session with Elias Jabbour from @mdanderson.bsky.social running through upcoming sessions at #ash24 very quickly (like only he can). Lots of great updates coming in the next few days in ALL

I have arrived at #ash24 (and on Bluesky). Excellent first talk to attend on multiple myeloma with @algarfall.bsky.social